(R)-1-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-ylsulfonyl)pyrrolidine-2-carboxylic acid

ID: ALA4171143

PubChem CID: 984803

Max Phase: Preclinical

Molecular Formula: C18H18N2O5S

Molecular Weight: 374.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)c2cccc3c(S(=O)(=O)N4CCC[C@@H]4C(=O)O)ccc1c23

Standard InChI:  InChI=1S/C18H18N2O5S/c1-2-19-13-8-9-15(11-5-3-6-12(16(11)13)17(19)21)26(24,25)20-10-4-7-14(20)18(22)23/h3,5-6,8-9,14H,2,4,7,10H2,1H3,(H,22,23)/t14-/m1/s1

Standard InChI Key:  GWXPEKYEANOENV-CQSZACIVSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    6.4509  -20.2152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4550  -21.0324    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.1606  -20.6202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4160  -23.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2345  -23.1364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6389  -22.4321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2315  -21.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6409  -21.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2377  -20.3248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4210  -20.3238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0153  -21.0253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0098  -22.4311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4154  -21.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2175  -21.3398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2159  -22.1758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5551  -22.6565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5424  -20.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8631  -21.7452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5748  -20.0644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5309  -22.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1393  -23.0437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8522  -22.6356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6842  -21.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2321  -21.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0311  -21.3967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9810  -20.4477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
 12  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
 13  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 13  2  0
 12 13  1  0
 14 15  1  0
 15 12  1  0
 14 11  1  0
 15 16  2  0
 14 17  1  0
  8  2  1  0
  2 18  1  0
 17 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 23 24  1  1
 24 25  2  0
 24 26  1  0
M  END

Associated Targets(Human)

BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPTEC (172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.42Molecular Weight (Monoisotopic): 374.0936AlogP: 2.06#Rotatable Bonds: 4
Polar Surface Area: 94.99Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.02CX Basic pKa: CX LogP: 1.45CX LogD: -2.02
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.88Np Likeness Score: -1.39

References

1. Feng Y, Xiao S, Chen Y, Jiang H, Liu N, Luo C, Chen S, Chen H..  (2018)  Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors.,  152  [PMID:29730189] [10.1016/j.ejmech.2018.04.048]

Source